ASBP
Aspire BioPharma, Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$5.68M
P/E Ratio
—
EPS
$-16.38
Beta
0.89
52W High
$35.01
52W Low
$0.55
50-Day MA
$1.28
200-Day MA
$9.02
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Aspire BioPharma, Inc.
Aspire Biopharma Holdings, Inc., early-stage biopharmaceutical company, engages in developing and marketing of disruptive technology for delivery mechanisms for do no harm drugs in the United States. The company is headquartered in Humacao, Puerto Rico.
Fundamentals
| Revenue (TTM) | 6,200 |
| Gross Profit (TTM) | -116 |
| EBITDA | — |
| Operating Margin | -375045.00% |
| Return on Equity | 0.00% |
| Return on Assets | -1657.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-1.80 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | 915.39 |
| EV/Revenue | 1477.32 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $5.02M |
| Float | $4.36M |
| % Insiders | 7.47% |
| % Institutions | 8.75% |
Data last updated: 4/7/2026